Thursday, 19 September 2019

Generics News

  • Sandoz gets FDA nod for MS generic drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2015

    Singapore: Sandoz, a Novartis company, has recieved USFDA approval of Glatopa, a first generic version of Teva's Copaxone (glatiramer acetate injection) for multiple sclerosis therapy. "Sa...Read more

  • Drug shortage forces FDA to approve cancer generic

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: The US FDA has provided its approval for a generic version of cancer drug Doxil that has been facing shortage due to manufacturing deficiencies. This generic version of the drug...Read more

  • Hong Kong to host international TCM exhibition, conference

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

    Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ) is organizing 12th International Conference and Exhibition of the M...Read more

  • Britain's MHRA recalls 16 Wockhardt medicines

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: UK's drug regulatory body, Medicines and Healthcare products Regulatory Agency (MHRA) has recalled 16 drugs manufactured by Wockhardt Ltd after identifying 'manufacturing deficie...Read more

  • Chinese planning agency to probe pharma prices

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

    Singapore: China's primary economic planning agency, the National Development and Reform Commission (NDRC) is in the process of investigating the costs and prices charged by drugmakers. Acc...Read more

  • Aurobindo recalls epilepsy drug lot in US

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2014

    Singapore: India-based Aurobindo Pharma in the US is recalling Gabapentin capsules, USP 300 mg 100-count bottles, at consumer level due to possible stashs of some empty capsules. USFDA has...Read more

  • Wockhardt restructures quality control team

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Sep, 2013

    Singapore: After being rapped by the US FDA and Indian drug regulator for lapses in good manufacturing practices (GMP), Indian drug major Wockhardt has now restructured its quality control ...Read more

  • GSK officials under criminal investigation in China

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: The Chinese police who have been investigating allegations of bribery against senior executives working at UK's leading multinational pharmaceutical company GlaxoSmithKline in Ch...Read more

  • Pneumonia kills a 5-year-old child every 30 secs: UN

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2013

    Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of more than one million girls and boys every year. However, the good n...Read more

  • Sanofi files first-of-a-kind suit against FDA

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

    Singapore: Sanofi has filed a lawsuit against the US FDA in hopes of preventing the regulatory agency from releasing packaging information of its newly approved over-the-counter (OTC) aller...Read more

  • “Chinese generics market has no strategy for international players”

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 17 Nov, 2014

    Singapore: In the last one year, Actavis has been aggressive in expanding its presence in Asia and the company was on an acquisition spree. Marking a direct presence in Asia, Actavis launch...Read more

  • US FDA imposes import alert on Ranbaxy drugs

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: The US FDA has issued an alert on import of Ranbaxy Laboratories drug products that are manufactured at its plant in Mohali, India. The firm will remain on the import alert unt...Read more

  • Apollo Pharmacy cautions against Ranbaxy drugs' use

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    New Delhi: Spelling further problems for India's pharma giant Ranbaxy and its Japanese owners Daiichi Sankyo, Apollo Pharmacy has issued a 'cautionary advisory' against the use of all drugs...Read more

  • Asian generic companies focus more on market expansion

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2015

    Singapore: A Frost & Sullivan (F&S) analysis finds that the Asian generic market is expected to grow at a compound annual growth rate of 17-18 percent between 2014 and 2018. The tea...Read more

  • Taiwan's TWi to independently hit the US market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2015

    Singapore: Taiwan-based TWi Pharmaceuticals has decided to sell its products in the US market through its own US subsidiary, instead of the original plan of selling through Teva Pharmaceuti...Read more

  • Comply or face action: US FDA tells Indian drugmakers

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: With increasing number of non-compliance issues being logged against Indian drugmakers by the US FDA, this time the American regulatory body has instructed the companies to eithe...Read more

  • Dr. Reddy's launches generic Finasteride

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

    Hyderabad: Dr. Reddy's Laboratories has launched Finasteride tablets (1 mg), a bioequivalent generic version of Propecia (Finasteride) in the US market on January 02, 2013. Dr. Reddy's A...Read more

  • Suzhou Amerigen launches Mecobalamin in China

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2014

    Singapore: US-based Amerigen Pharmaceuticals' Chinese subsidiary, Suzhou Amerigen Pharmaceuticals has received Chinese FDA (CFDA) approval for its generic Mecobalamin 0.5 mg tablets. The co...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls